Clinical significance of selected angiogenesis and lymphangiogenesis modulators and markers in ovarian cancer patients. Tolerability of long-term use of trabectedin (Tr) in combination with pegylated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback